Who owns PLIANT THERAPEUTICS INC COM?
- Ticker: PLRX
- CUSIP Number: 729139105
Tip: Access positions for across all investors
Analyze quarterly positions in Pliant Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pliant Therapeutics stock
Who bought or sold PLIANT THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tang Capital Management | 6.1M | $7.7M | 0% | Mar 2026 |
|
| Citadel Advisors | 3.3M | $4.1M | 20% | Mar 2026 |
|
| Blue Owl Capital Holdings | 3.0M | $3.6M | 0% | Dec 2025 |
|
| Vanguard Group | 2.8M | $3.4M | 2% | Dec 2025 |
|
| ADAR1 Capital Management | 2.6M | $3.3M | 3402% | Mar 2026 |
|
| Acadian Asset Management | 2.4M | $3.0M | 2% | Mar 2026 |
|
| Vanguard Capital Management | 2.3M | $3.0M | 100% | Mar 2026 |
|
| Two Sigma Investments | 2.3M | $2.8M | 136% | Mar 2026 |
|
| Monaco Asset Management SAM | 1.9M | $2.4M | 0% | Mar 2026 |
|
| Woodline Partners | 1.7M | $2.1M | -18% | Mar 2026 |
|
| Prosight Management | 1.6M | $1.9M | 7494% | Dec 2025 |
|
| BML Capital Management | 1.5M | $1.9M | 0% | Mar 2026 |
|
| Peapod Lane Capital | 1.3M | $1.6M | 45% | Mar 2026 |
|
| Millennium Management | 1.2M | $1.5M | 189% | Mar 2026 |
|
| BlackRock | 1.1M | $1.4M | 2% | Mar 2026 |
|
| Marshall Wace | 1.1M | $1.3M | 261% | Dec 2025 |
|
| UBS Group | 1.1M | $1.3M | 0% | Mar 2026 |
|
| Renaissance Technologies | 1.0M | $1.3M | 3% | Dec 2025 |
|
| Eversept Partners | 842k | $1.0M | 2% | Dec 2025 |
|
| Redmile Group | 772k | $973k | -52% | Mar 2026 |
|
| Jacobs Levy Equity Management | 719k | $905k | 29% | Mar 2026 |
|
| Goldman Sachs Group | 597k | $752k | 116% | Mar 2026 |
|
| XTX Topco | 545k | $665k | 17% | Dec 2025 |
|
| Bessemer | 532k | $670k | 0% | Mar 2026 |
|
| Connor, Clark & Lunn Investment Management | 518k | $652k | 39% | Mar 2026 |
|
| Morgan Stanley | 506k | $506k | -8% | Mar 2026 |
|
| DAFNA Capital Management | 487k | $614k | 100% | Mar 2026 |
|
| Centiva Capital | 433k | $545k | -57% | Mar 2026 |
|
| Geode Capital Management | 417k | $526k | -30% | Mar 2026 |
|
| GSA Capital Partners | 402k | $507k | -36% | Mar 2026 |
|
| Jane Street | 369k | $465k | -44% | Mar 2026 |
|
| Bank of America Corporation | 353k | $444k | 100% | Mar 2026 |
|
| Torno Capital | 350k | $441k | 9% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 340k | $428k | 100% | Mar 2026 |
|
| Bridgeway Capital Management | 322k | $392k | 291% | Dec 2025 |
|
| Sei Investments | 297k | $270k | 0% | Mar 2026 |
|
| Arrowpoint Asset Management | 281k | $354k | 0% | Mar 2026 |
|
| Laurion Capital Management | 257k | $314k | 100% | Dec 2025 |
|
| State Street Corporation | 253k | $309k | 0% | Dec 2025 |
|
| Susquehanna International | 249k | $304k | 15% | Dec 2025 |
|
| Nano Cap New Millennium Growth Fund | 235k | $287k | 100% | Dec 2025 |
|
| Stonepine Capital Management | 230k | $281k | -20% | Dec 2025 |
|
| Rangeley Capital | 225k | $284k | 0% | Mar 2026 |
|
| HighMark Wealth Management | 166k | $209k | -3% | Mar 2026 |
|
| Squarepoint Ops | 163k | $206k | 65% | Mar 2026 |
|
| Vanguard Portfolio Management | 154k | $194k | 100% | Mar 2026 |
|
| Diadema Partners | 145k | $177k | 100% | Dec 2025 |
|
| Northern Trust | 123k | $150k | -10% | Dec 2025 |
|
| Invesco | 115k | $145k | 1% | Mar 2026 |
|
| Advisor Group Holdings | 115k | $140k | -8% | Dec 2025 |
|
| Hennion & Walsh Asset Management | 107k | $134k | -6% | Mar 2026 |
|
| Bond & Devick Financial Network | 100k | $126k | 0% | Mar 2026 |
|
| Dimensional Fund Advisors | 100k | $126k | -18% | Mar 2026 |
|
| Quadrature Capital | 98k | $119k | 100% | Dec 2025 |
|
| Algert Coldiron Investors | 85k | $106k | 0% | Mar 2026 |
|
| Federated Investors | 63k | $79k | 5% | Mar 2026 |
|
| Ameriprise Financial | 55k | $70k | 100% | Mar 2026 |
|
| Point72 Asset Management | 47k | $59k | 1% | Mar 2026 |
|
| Simplex Trading | 46k | $56k | 253% | Dec 2025 |
|
| Engineers Gate Manager | 31k | $37k | 30% | Dec 2025 |
|
| Tudor Investment Corporation | 30k | $38k | 0% | Mar 2026 |
|
| Blackstone Group | 22k | $28k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 20k | $25k | 100% | Mar 2026 |
|
| Bronte Capital Management Pty | 19k | $24k | 0% | Mar 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 18k | $23k | 0% | Mar 2026 |
|
| Bank of New York Mellon | 16k | $20k | 0% | Mar 2026 |
|
| Qube Research & Technologies | 15k | $19k | -69% | Dec 2025 |
|
| SG Americas Securities | 13k | $16k | 3% | Mar 2026 |
|
| Fiduciary Trust Company | 12k | $14k | 0% | Dec 2025 |
|
| Hrt Financial | 11k | $14k | -65% | Mar 2026 |
|
| Barclays | 11k | $13k | -97% | Dec 2025 |
|
| JustInvest | 10k | $13k | -62% | Mar 2026 |
|
| Rhumbline Advisers | 2.4k | $3.0k | 0% | Mar 2026 |
|
| Owl Creek Wealth Partners | 2.3k | $2.9k | 100% | Mar 2026 |
|
| FMR | 1.9k | $2.4k | -61% | Dec 2025 |
|
| Royal Bank of Canada | 997.00 | $2.2k | -94% | Mar 2026 |
|
| Rockefeller Capital Management | 660.00 | $831.996000 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 657.00 | $828.017100 | 0% | Mar 2026 |
|
| Harbour Investments | 488.00 | $614.977600 | 100% | Mar 2026 |
|
| Bare Financial Services | 413.00 | $503.983900 | 100% | Dec 2025 |
|
| MAI Wealth Advisors | 400.00 | $504.000000 | 0% | Mar 2026 |
|
| CWM | 391.00 | $0 | -40% | Dec 2025 |
|
| SBI Securities | 300.00 | $378.000000 | -6% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 100.00 | $126.000000 | 100% | Mar 2026 |
|
| Wells Fargo & Company | 50.00 | $63.000000 | 0% | Mar 2026 |
|
| Truvestments Capital | 50.00 | $63.000000 | 0% | Mar 2026 |
|
| Zurcher Kantonalbank | 36.00 | $45.000000 | 0% | Mar 2026 |
|
| Capital Advisors | 20.00 | $0 | 100% | Mar 2026 |
|
| Brian McDonald | 6.00 | $7.000200 | -57% | Dec 2025 |
|
| Farther Finance Advisors | 5.00 | $7.000000 | 0% | Mar 2026 |
|
| Fifth Third Bancorp | 4.00 | $5.000000 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 4.00 | $5.000000 | 300% | Mar 2026 |
|
| Global Retirement Partners | 4.00 | $5.000000 | 0% | Dec 2025 |
|
Who sold out of Pliant Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Sep 2025 | 2.1M | $3.2M |
| Two Sigma Advisers | Dec 2025 | 1.2M | $1.5M |
| Seven Fleet Capital Management | Dec 2025 | 277k | $337k |
| Rice Hall James & Associates | Dec 2025 | 148k | $180k |
| Canada Pension Plan Investment Board | Dec 2025 | 61k | $75k |
| Bluefin Capital Management | Sep 2025 | 41k | $61k |
| DekaBank Deutsche Girozentrale | Dec 2025 | 40k | $633k |
| Persistent Asset Partners | Dec 2025 | 39k | $47k |
| Tower Research Capital | Sep 2025 | 21k | $31k |
| Group One Trading | Dec 2025 | 16k | $19k |
| Quest Partners | Dec 2025 | 12k | $14k |
| Fortitude Family Office | Dec 2025 | 1.3k | $1.6k |
| Pnc Financial Services | Dec 2025 | 978.00 | $1.2k |
| Russell Investments | Dec 2025 | 542.00 | $661.023200 |
| Covestor | Dec 2025 | 45.00 | $0 |